Max Healthcare Institute Earnings Call Transcript: Key Takeaways
Max Healthcare maintains strong momentum with 20% revenue growth, driven by rapid brownfield ramp-ups and improved ARPOB despite a 14% capacity increase.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Max Healthcare maintains strong momentum with 20% revenue growth, driven by rapid brownfield ramp-ups and improved ARPOB despite a 14% capacity increase.
Max Healthcare Q1 FY27 revenue grew 16% YoY to INR 2,982 Cr. Operating EBITDA rose 15% to INR 704 Cr. Strategy focuses on aggressive brownfield expansions and entering the medical education business.
Max Healthcare delivered strong Q1 FY27 results with Net Revenue growing 15% YoY to ₹2,835 Cr and Operating EBITDA rising 15% to ₹704 Cr, driven by improved ARPOB and occupancy.
Max Healthcare delivered Q4 FY26 revenue of INR 2,664 Cr (+10% YoY) and FY26 PAT of INR 1,631 Cr (+22% YoY).
Max Healthcare (MHIL) reports strong FY26 performance with 16% revenue growth and 14% EBITDA growth. The company maintains a 26.2% EBITDA margin while executing an aggressive 8,400+ bed expansion strategy.